Results 171 to 180 of about 18,956 (224)
Targeting formyl peptide receptor 2 to suppress neuroinflammation in neuromyelitis optica spectrum disorder. [PDF]
Qi C +12 more
europepmc +1 more source
Data showing effects of resolvin D<sub>5</sub> on prostaglandin E<sub>2</sub> mediated inhibition of fMet-Leu-Phe induced activation of the NADPH oxidase in human neutrophils. [PDF]
Li W, Dahlgren C, Forsman H.
europepmc +1 more source
Molecular mechanisms of acute inflammation: systemic responses and kidney-specific pathophysiology. [PDF]
Chelangarimiyandoab F +4 more
europepmc +1 more source
FDA approves lurbinectedin in combination with atezolizumab for extensive-stage small cell lung cancer. [PDF]
Kepp O, Kroemer G.
europepmc +1 more source
A versatile route towards 6-arylpipecolic acids. [PDF]
Gebel E, Göcke C, Gruner C, Sewald N.
europepmc +1 more source
Elevated LL-37/FPR2 Axis and its Regulatory Role for Gingival Fibroblasts in Periodontitis. [PDF]
Lin T +10 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Formyl peptide receptors in bone research
Connective Tissue Research, 2022The formyl peptide receptor (FPR) participates in the immune response, with roles in infection and inflammation. In this review article, we summarize the current literature on these roles before discussing the function of FPRs in the pathogenesis of musculoskeletal disorders including osteoarthritis (OA), degenerative disc disease (DDD), and rheumatoid
Mark A, Lantieri +5 more
openaire +2 more sources

